Correction: Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial.
Resource Type
Authors
de Vlam K; University Hospital Leuven, Leuven, Belgium. kurt.devlam@uzleuven.be.; Maksymowych WP; Department of Medicine, Division of Rheumatology at the University of Alberta, Edmonton, Alberta, Canada.; Gallo G; Eli Lilly and Company, Indianapolis, USA.; Rahman P; Department of Medicine, Memorial University, St. John's, Newfoundland, A1C 5B8, Canada.; Mease P; Swedish Medical Center/Providence St, Joseph Health and University of Washington, Seattle, Washington, USA.; Krishnan V; Eli Lilly and Company, Indianapolis, USA.; McVeigh CJ; Eli Lilly and Company, Indianapolis, USA.; Lisse J; Eli Lilly and Company, Indianapolis, USA.; Zhu D; Eli Lilly and Company, Indianapolis, USA.; Bolce RJ; Eli Lilly and Company, Indianapolis, USA.; Conaghan PG; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds, UK.
Source
Publisher: Springer Healthcare Country of Publication: England NLM ID: 101674543 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2198-6576 (Print) Linking ISSN: 21986576 NLM ISO Abbreviation: Rheumatol Ther